Cartesian Therapeutics, Inc. Proceeds from Issuance of Warrants
Cartesian Therapeutics, Inc. (RNAC) reported Proceeds from Issuance of Warrants of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2023-11-13
- Cartesian Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2023-09-30 was $0.00.
- Cartesian Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2022-12-31 was $0.00.
- Cartesian Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2022-09-30 was -$31.00K.
- Cartesian Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2022 was $36.86M.
- Cartesian Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2021 was $0.00.
- Cartesian Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2020 was $0.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-17 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$31.00K derived: sum of 2 quarters · filed 2023-11-13 | $36.86M 10-K · filed 2023-03-02 | |
| 2022-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $36.86M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $36.89M 10-Q · filed 2023-08-17 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-02 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |